Allianz Is the World’s #1 Insurance Brand, Ranking Among the Top 30 Global Brands for the First Time
10.10.2024 11:03:00 CEST | Business Wire | Press release
Interbrand 2024 Best Global Brands ranking: Allianz jumps to 29th position and further maximises brand value to 23,5 billion USD.Strong employee value proposition: Allianz also climbed to 7th place in the Fortune 100 Best Companies to Work For® in Europe 2024 certification.The 2024 Olympic and Paralympic Games in Paris have been the biggest marketing asset to date for Allianz, uniting athletes from over 200 nations and billions of fans in peaceful competitions.Disaster relief efforts for flood events and sustainability commitments contribute to building trust in the Allianz brand.
Allianz's steady rise to the top of the world's most powerful brands continued in 2024, driven by a strong employee value proposition, a commitment to building trust through sustainability and societal leadership as well as top-tier partnerships in sport. For the first time, Allianz has been named one of the 30 most valuable brands in the world, moving up two places to the 29th position in this year’s Best Global Brands ranking from Interbrand.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241010002189/en/

Oliver Bäte, CEO, Allianz SE (Photo: Business Wire)
The global insurer with 125 million customers and 157,000 employees has also been recognized as the most valuable financial services brand for the sixth consecutive time, increasing its brand value to 23.5 billion USD (2023: $20.85 billion) and outperforming the financial services sector growth by 7%.
In addition, Allianz was recognized for its strong employer brand and benefits, reaching rank 7 in the Fortune 100 Best Companies to Work For® in Europe2024certification, also announced today. With its flexible working model, a wide range of benefits and development opportunities and a steadfast commitment to diversity and inclusion, Allianz is attractive to employees and candidates alike. Globally, 52 Allianz entities are already certified and 16 are currently on the national best lists for their countries.
“Our brand strength reflects the fundamental value that Allianz and our employees provide: instilling confidence in the future by bringing security and peace of mind to our customers around the globe. Whether safeguarding global sporting events, like the Paris 2024 Olympic and Paralympic Games, or supporting homeowners in the wake of catastrophic flood damage, Allianz protects and delivers what people value most,” said Oliver Bäte, CEO of Allianz SE.
Creating trust as sustainability leader
Insurance is an intangible but stabilizing force for individuals and businesses. At the core of Allianz’s brand promise is the commitment to secure the future of its customers and employees. With the growing impact of climate change, Allianz focuses on supporting customers to become more resilient and expanding the role of insurers in addressing societal challenges. Allianz is widely regarded as a global frontrunner in sustainability, with an ambitious and measurable net-zero transition plan to decarbonize its proprietary property and casualty insurance and investment portfolios. Our commitment is further underscored by Allianz’ social initiatives such as humanitarian aid support and on-the-ground response to communities impacted by the recent floods in Germany in June 2024 and Central Europe in September 2024, as well as its role as a founding partner of ‘Humanity Insured’, an international non-profit organization with the vision to bring insurance-led climate resilience to billions of people.
Paris 2024 – an iconic brand moment for Allianz
Uniting athletes and fans from around the world in peaceful competitions and in a shared belief in openness, respect and inclusion, Allianz helped deliver the Paris 2024 Olympic and Paralympic Games. As exclusive insurance partner of the Olympic and Paralympic Movements, Allianz provided a wide range of solutions for organizers, fans and athletes. The unique festival of sports with many record-breaking athlete performances and spectacular venues engaged over half of the world’s population via broadcast or digital channels.
“The Games have been the iconic brand moment in 2024 and the most significant marketing asset for Allianz to date.Our global ‘One Brand’ strategy under the purpose-driven Allianz master brand is paying off resulting in what is the highest brand value Allianz has ever achieved. Our strong brand is the foundation for growth by helping attract new customers – all based on our promise of giving people confidence in tomorrow,” says Bernd Heinemann, Chief Strategy, Marketing and Distribution Officer at Allianz SE.
In the lead-up to the Games, Allianz launched its global "Get Ready" campaign across more than 60 markets connecting with millions of customers, consumers and business partners around the world. The activation included 11 broadcast sponsorships, large-scale outdoor advertisements like a giant banner at Tour Neptune or securing over 1 billion impressions in social media globally with 150 content assets in 20 languages. Allianz employees played a key role as brand ambassadors onsite in Paris as torchbearers, volunteers, spectators, and fans.
Partnerships with FC Bayern and Rugby Football Union extended
Leveraging high-profile sport partnerships for creating emotional brand-experience moments, Allianz has extended its long-standing partnership with FC Bayern in 2024. Allianz welcomed Harry Kane as a brand ambassador; as the new sleeve sponsor of FC Bayern men's team, Allianz is engaging with fans through QR-codes on the shirts, leading to prize draws or raffles.
Further expanding its global family of world-class stadiums, Allianz announced the extension of its partnership with the Rugby Football Union (RFU) and the renaming of Twickenham Stadium to Allianz Stadium in the United Kingdom. The MoveNow Program promotes healthy physical activity for youth. In addition to these global initiatives, many Allianz business entities support national clubs and sport federations in their home markets.
Downloads |
Further links |
Allianz donates up to €1.5 million to support disaster relief efforts Allianz welcomes FC Bayern footballer Harry Kane as Allianz brand ambassador | |
About Allianz
The Allianz Group is one of the world's leading insurers and asset managers with around 125 million* private and corporate customers in nearly 70 countries. Allianz customers benefit from a broad range of personal and corporate insurance services, ranging from property, life and health insurance to assistance services to credit insurance and global business insurance. Allianz is one of the world’s largest investors, managing around 741 billion euros** on behalf of its insurance customers. Furthermore, our asset managers PIMCO and Allianz Global Investors manage about 1.8 trillion euros** of third-party assets. Thanks to our systematic integration of ecological and social criteria in our business processes and investment decisions, we are among the leaders in the insurance industry in the Dow Jones Sustainability Index. In 2023, over 157,000 employees achieved total business volume of 161.7 billion euros and an operating profit of 14.7 billion euros for the group.
* Including non-consolidated entities with Allianz customers.
**As of June 30, 2024.
Mandatory corporate information: Corporate disclosures
These assessments are, as always, subject to the disclaimer provided below.
Cautionary note regarding forward-looking statements
This document includes forward-looking statements, such as prospects or expectations, that are based on management's current views and assumptions and subject to known and unknown risks and uncertainties. Actual results, performance figures, or events may differ significantly from those expressed or implied in such forward-looking statements.
Deviations may arise due to changes in factors including, but not limited to, the following: (i) the general economic and competitive situation in the Allianz’s core business and core markets, (ii) the performance of financial markets (in particular market volatility, liquidity, and credit events), (iii) adverse publicity, regulatory actions or litigation with respect to the Allianz Group, other well-known companies and the financial services industry generally, (iv) the frequency and severity of insured loss events, including those resulting from natural catastrophes, and the development of loss expenses, (v) mortality and morbidity levels and trends, (vi) persistency levels, (vii) the extent of credit defaults, (viii) interest rate levels, (ix) currency exchange rates, most notably the EUR/USD exchange rate, (x) changes in laws and regulations, including tax regulations, (xi) the impact of acquisitions including related integration issues and reorganization measures, and (xii) the general competitive conditions that, in each individual case, apply at a local, regional, national, and/or global level. Many of these changes can be exacerbated by terrorist activities.
No duty to update
Allianz assumes no obligation to update any information or forward-looking statement contained herein, save for any information we are required to disclose by law.
Privacy Note
Allianz SE is committed to protecting your personal data. Find out more in our privacy statement.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241010002189/en/



Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom